
Overview
Xiaojun Wu, M.D., Ph.D. is as assistant professor of pathology at Sibley Memorial Hospital where she will lead their hematopathology program. Dr. Wu received her M.D. from Zhejiang Medical University in China, and her Ph.D. from the University of Alabama at Birmingham. She continued at the University of Alabama at Birmingham for pathology residency training, followed by a fellowship in hematopathology. She then moved to New York where she completed a surgical pathology fellowship at Memorial Sloan Kettering Cancer Center. She subsequently joined the faculty at New York University from 2013-2015 and moved to the Washington area in 2015 and joined the faculty at George Washington University from 2015-2016. She has been with Johns Hopkins since 2016. Dr. Wu has 15 peer-reviewed publications, primarily in the field of hematopathology.
Dr. Wu is highly rated in 2 conditions, according to our data. Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Acute Myeloid Leukemia (AML).
Her clinical research consists of co-authoring 47 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
Locations
Washington, DC 20016
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 29 conditions, according to our data. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.
Rubenstein Child Health Building
Dr. Howard Lederman is a professor of pediatrics at the Johns Hopkins University School of Medicine. He is the director of the Immunodeficiency Clinic, the Pediatric Immunology Laboratory, and the Ataxia-Telangiectasia (A-T) Clinical Center. Dr. Lederman specializes in the evaluation, diagnostic testing and long-term management of patients of all ages who have known or suspected primary immunodeficiency diseases. He is an expert on the use of gamma globulin therapy for a wide variety of disorders. After receiving his M.D. and Ph.D. from the University of Michigan, Dr. Lederman came to Johns Hopkins Children’s Center for a residency in pediatrics, followed by a fellowship in immunology at the Hospital for Sick Children in Toronto. Dr. Lederman’s current research laboratory and clinical research focuses on better understanding and treating patients with ataxia-telangiectasia, a devastating neurological disorder for which there is no cure. He is a member of numerous professional societies, including American Association of Immunologists, the American Society for Microbiology and the Clinical Immunology Society. Dr. Lederman is highly rated in 2 conditions, according to our data. His top areas of expertise are Common Variable Immune Deficiency, X-Linked Agammaglobulinemia, Hyper IgE Syndrome, and Autosomal Dominant Hyper IgE Syndrome.
The Johns Hopkins Hospital
Dr. Jaroslaw Jedrych is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatopathology and anatomic pathology. Dr. Jedrych received his M.D. from the Warsaw Medical University. He completed his residency in anatomic pathology at Yale School of Medicine, where he served as chief resident. He then completed his fellowship in oncologic pathology at Memorial Sloan Kettering Cancer Center, where he served as chief fellow, and a dermatopathology fellowship at University of Pittsburgh Medical Center. Dr. Jedrych is highly rated in 3 conditions, according to our data. His top areas of expertise are Epidermodysplasia Verruciformis, Trichoepithelioma, Warts, and Grover's Disease.
Frequently Asked Questions about Dr. Xiaojun Wu
How do I make an appointment with Dr. Xiaojun Wu?
You can book an appointment with Dr. Xiaojun Wu by calling their office at 202-537-4000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Xiaojun Wu a top-rated expert for Large-Cell Immunoblastic Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Xiaojun Wu is classified as an Advanced expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Xiaojun Wu specialize in?
While Dr. Xiaojun Wu is a Pathology, they have specific expertise in Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pathology.
Does Dr. Xiaojun Wu participate in research or clinical trials?
Yes. Dr. Xiaojun Wu has published 47 articles and abstracts on conditions like Large-Cell Immunoblastic Lymphoma. You can view a list of Dr. Xiaojun Wu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Xiaojun Wu accept my insurance?
Dr. Xiaojun Wu accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 202-537-4000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaDr. Wu isAdvanced. Learn about B-Cell Lymphoma.
- Large-Cell Immunoblastic Lymphoma
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Wu isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid Leukemia
- Chronic B-Cell Leukemia (CBCL)Dr. Wu isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).


